Skip to Main Content

Paper Details

NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma.
Invest New Drugs
9
2020

Datasets

Release 1.2